These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31067371)

  • 41. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.
    Saccone G; Schoen C; Franasiak JM; Scott RT; Berghella V
    Fertil Steril; 2017 Feb; 107(2):430-438.e3. PubMed ID: 27887710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
    Tomic V; Tomic J; Klaic DZ; Kasum M; Kuna K
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cervical Pessary Compared With Vaginal Progesterone for Preventing Early Preterm Birth: A Randomized Controlled Trial.
    Cruz-Melguizo S; San-Frutos L; Martínez-Payo C; Ruiz-Antorán B; Adiego-Burgos B; Campillos-Maza JM; García-González C; Martínez-Guisasola J; Pérez-Carbajo E; Teulón-González M; Avendaño-Solá C; Pérez-Medina T
    Obstet Gynecol; 2018 Oct; 132(4):907-915. PubMed ID: 30204689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early-pregnancy events and subsequent antenatal, delivery and neonatal outcomes: prospective cohort study.
    Al-Memar M; Vaulet T; Fourie H; Nikolic G; Bobdiwala S; Saso S; Farren J; Pipi M; Van Calster B; de Moor B; Stalder C; Bennett P; Timmerman D; Bourne T
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):530-537. PubMed ID: 30887596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expanded findings from a randomized controlled trial of preconception low-dose aspirin and pregnancy loss.
    Mumford SL; Silver RM; Sjaarda LA; Wactawski-Wende J; Townsend JM; Lynch AM; Galai N; Lesher LL; Faraggi D; Perkins NJ; Schliep KC; Zarek SM; Schisterman EF
    Hum Reprod; 2016 Mar; 31(3):657-65. PubMed ID: 26759138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progestogen for preventing miscarriage.
    Haas DM; Ramsey PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD003511. PubMed ID: 24173668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaginal bleeding and nausea in early pregnancy as predictors of clinical pregnancy loss.
    DeVilbiss EA; Naimi AI; Mumford SL; Perkins NJ; Sjaarda LA; Zolton JR; Silver RM; Schisterman EF
    Am J Obstet Gynecol; 2020 Oct; 223(4):570.e1-570.e14. PubMed ID: 32283071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study.
    da Fonseca EB; Bittar RE; Carvalho MH; Zugaib M
    Am J Obstet Gynecol; 2003 Feb; 188(2):419-24. PubMed ID: 12592250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined use of oestradiol and progesterone to support luteal phase in antagonist intracytoplasmic sperm injection cycles of normoresponder women: a case-control study.
    Çakar E; Tasan HA; Kumru P; Cogendez E; Usal NT; Kutlu HT; Özkaya E; Eser SK
    J Obstet Gynaecol; 2020 Feb; 40(2):264-269. PubMed ID: 31455122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complications of first-trimester abortion by vacuum aspiration after cervical preparation with and without misoprostol: a multicentre randomised trial.
    Meirik O; My Huong NT; Piaggio G; Bergel E; von Hertzen H;
    Lancet; 2012 May; 379(9828):1817-24. PubMed ID: 22405255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized trial of micronized progesterone for the prevention of recurrent preterm birth.
    Glover MM; McKenna DS; Downing CM; Smith DB; Croom CS; Sonek JD
    Am J Perinatol; 2011 May; 28(5):377-81. PubMed ID: 21380990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitrified blastocyst transfer cycles with the use of only vaginal progesterone replacement with Endometrin have inferior ongoing pregnancy rates: results from the planned interim analysis of a three-arm randomized controlled noninferiority trial.
    Devine K; Richter KS; Widra EA; McKeeby JL
    Fertil Steril; 2018 Feb; 109(2):266-275. PubMed ID: 29338855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of prenatal vaginal progesterone on cervical length in nonselected twin pregnancies.
    Agra IKR; Carvalho MHB; Hernandez WR; Francisco RPV; Zugaib M; Brizot ML
    J Matern Fetal Neonatal Med; 2019 Apr; 32(8):1245-1249. PubMed ID: 29117757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India.
    Majhi P; Bagga R; Kalra J; Sharma M
    J Obstet Gynaecol; 2009 Aug; 29(6):493-8. PubMed ID: 19697195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double-blind controlled trial of progesterone substitution in threatened abortion.
    Gerhard I; Gwinner B; Eggert-Kruse W; Runnebaum B
    Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):26-34. PubMed ID: 2437967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaginal progesterone to prevent preterm delivery among HIV-infected pregnant women in Zambia: A feasibility study.
    Price JT; Phiri WM; Freeman BL; Vwalika B; Winston J; Mabula-Bwalya CM; Mulenga HB; Stringer JSA
    PLoS One; 2020; 15(1):e0224874. PubMed ID: 31995557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
    Hoffman MK; Goudar SS; Kodkany BS; Metgud M; Somannavar M; Okitawutshu J; Lokangaka A; Tshefu A; Bose CL; Mwapule A; Mwenechanya M; Chomba E; Carlo WA; Chicuy J; Figueroa L; Garces A; Krebs NF; Jessani S; Zehra F; Saleem S; Goldenberg RL; Kurhe K; Das P; Patel A; Hibberd PL; Achieng E; Nyongesa P; Esamai F; Liechty EA; Goco N; Hemingway-Foday J; Moore J; Nolen TL; McClure EM; Koso-Thomas M; Miodovnik M; Silver R; Derman RJ;
    Lancet; 2020 Jan; 395(10220):285-293. PubMed ID: 31982074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009154. PubMed ID: 26148507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progestogen for preventing miscarriage.
    Oates-Whitehead RM; Haas DM; Carrier JA
    Cochrane Database Syst Rev; 2003; (4):CD003511. PubMed ID: 14583982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early progesterone cessation after in vitro fertilization/intracytoplasmic sperm injection: a randomized, controlled trial.
    Kohls G; Ruiz F; Martínez M; Hauzman E; de la Fuente G; Pellicer A; Garcia-Velasco JA
    Fertil Steril; 2012 Oct; 98(4):858-62. PubMed ID: 22749223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.